Machioka Kazuaki, Mizokami Atsushi, Yamaguchi Yuri, Izumi Kouji, Hayashi Shinichi, Namiki Mikio
Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Sciences, Ishikawa, Japan.
Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Sciences, Ishikawa, Japan
Anticancer Res. 2015 Jan;35(1):221-7.
It remains unclear whether estrogen is produced in prostate cancer (PCa) and how it functions in PCa.
To examine the production of estrogen in PCa cells, the concentration of estrogen in the medium in which LNCaP cells and PCa-derived stromal cells (PCaSC) were co-cultured, was measured by liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS), while aromatase (CYP19) mRNA expression was confirmed by real-time polymerase chain reaction (RT-PCR) methods. To verify whether estrogen is synthesized from testosterone in PCaSC functions, PCaSC were co-cultured with breast cancer MCF-7-E10 cells, which were stably-transfected with ERE-GFP, in the presence of testosterone. GFP expression was detected when PCaSCs could synthesize estrogen. The proliferation of PC-3 cells in the presence of PCaSC was determined by cell count.
PCaSC metabolized excessive testosterone to estrogen, which activated estrogen receptor in breast cancer cells. Moreover, estrogen synthesized from testosterone in PCaSC regulated the proliferation of PC-3 cell via repression of some unknown growth factors that were secreted from PCaSC.
A chimeric co-culture method between breast cancer cells and PCaSC revealed the production of active estrogen in PCaSC. High-dose testosterone therapy might introduce a new potential strategy to treat CRPC.
目前尚不清楚前列腺癌(PCa)中是否产生雌激素以及它在PCa中如何发挥作用。
为检测PCa细胞中雌激素的产生,采用液相色谱-质谱联用/质谱(LC-MS/MS)法测定LNCaP细胞与PCa来源的基质细胞(PCaSC)共培养的培养基中雌激素的浓度,同时采用实时聚合酶链反应(RT-PCR)法确认芳香化酶(CYP19)mRNA的表达。为验证PCaSC功能中雌激素是否由睾酮合成,在睾酮存在的情况下,将PCaSC与稳定转染了ERE-GFP的乳腺癌MCF-7-E10细胞共培养。当PCaSC能够合成雌激素时,检测GFP表达。通过细胞计数确定PCaSC存在时PC-3细胞的增殖情况。
PCaSC将过量的睾酮代谢为雌激素,从而激活乳腺癌细胞中的雌激素受体。此外,PCaSC中由睾酮合成的雌激素通过抑制PCaSC分泌的一些未知生长因子来调节PC-3细胞的增殖。
乳腺癌细胞与PCaSC之间的嵌合共培养方法揭示了PCaSC中活性雌激素的产生。高剂量睾酮治疗可能为治疗去势抵抗性前列腺癌(CRPC)引入一种新的潜在策略。